The F.L. "Bud" Suddath and Frances "Lee" Gafford Suddath Fellowship Award was established by Bud Suddath's family, friends, and colleagues in memory of his contributions to Georgia Tech. The award is given annually to graduate students at Georgia Tech who have demonstrated significant bio-research accomplishments while conducting biological or biochemical research at the molecular or cellular level.
After considerable deliberation, a committee of IBB faculty selected three Ph.D. candidates as the 2024 Suddath Award winners from an extremely strong group of applicants:
In Third place, with a cash award of $250
Raghav is working on his Ph.D. in Machine Learning with Prof. Cassie S. Mitchell within the Coulter Department of Biomedical Engineering.
Raghav’s research is focused on using machine learning algorithms to identify biomarkers, from diverse data modalities such as omics and neuroimaging, to model the progression of neuro-degenerative diseases, such as Alzheimer’s Disease.
In Second place, with a cash award of $500
Kathryn is working on her Ph.D. in Bioengineering with Prof. Ravi Kane within the School of Chemical Engineering
Kathryn’s research has focused on the design of broadly protective coronavirus vaccines. This includes a vaccine that protects against multiple coronaviruses variants, as well as a cocktail vaccine developed to protect against not just SARS-CoV-2 and CoV-1 variants, but also various bat and pangolin coronaviruses that could pose a threat to humans.
In First place, with a cash award of $1000, and the opportunity to present a research seminar at the start of the 2024 Suddath Symposium this coming March.
Andrew is working on his Ph.D. with Prof. Johnny Blazeck within the School of Chemical and Biomolecular Engineering.
Andrew's research has focused on the development of technologies for targeted DNA diversification in Saccharomyces cerevisiae for applications in antibody engineering and directed evolution. Thenovel yeast-based platform developed by Andrew will facilitate the study of immune receptor repertoires and the isolation of clinically relevant antibodies with enhanced affinities.
IBB is excited to congratulate our 2024 Suddath Awardees and to all of the year’s applicants for their impressive accomplishments!
]]>